Hadassah

Hadassah Heart Specialists Reveal Detrimental Effect of Thyroid Imbalance on Heart Failure Patients

Wednesday, Apr 23 2014


A study by the Hadassah Medical Organization's heart specialists has revealed that increased levels of thyroid-stimulating hormone (TSH) are correlated with "worse clinical outcome" in patients suffering from heart failure. "Thyroid imbalance," they report, "confers significant risk in heart failure and warrants attention." While it has been known that thyroid dysfunction affects cardiac function and is a risk factor for heart failure, the scientists report, "data regarding the clinical significance of TSH levels alone as a predictor of outcome in patients with heart failure is sparse." Their study evaluated the significance of TSH on clinical outcome in a large cohort of patients with chronic heart failure.

Study findings reveal that both a high and a low TSH level are associated with an increased mortality rate. In addition, TSH was also an independent predictor of death and cardiac-related hospitalization. For those patients not receiving thyroid hormone treatment, "TSH was an even stronger predictor of mortality." At the same time, increasing TSH levels above normal were "independently associated with increased mortality and cardiac-related hospitalizations." The study, entitled "The Effect of Thyroid Function on Clinical Outcome in Patients with Heart Failure," was published in the February 2014 issue of the European Journal of Heart Failure (Volume 16, Issue 2).

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jul 11 2018

Improving Kidney Health of Premature Babies

Is the TV hit show Grey's Anatomy taking its inspiration from Hadassah Hospital? After all, cast members did visit Hadassah Ein Kerem in 2011. Dr. Oded Volovelsky, Head of Hadassah's new Pediatric Nephrology Unit says, only half-jokingly, that TV doc Meredith Grey might have read his research.

READ MORE ›
alt_text

Wednesday, Jul 11 2018

Hadassah Cancer Specialists Explore Link Between Colorectal Cancer and BRCA Mutations

Looking further into the link between colorectal cancer and BRCA 1 and 2 genetic mutations, researchers from the Hadassah Medical Center’s Sharett Institute of Oncology, together with colleagues from Chaim Sheba Medical Center, analyzed data from 32 patients with lower gastrointestinal cancers.

READ MORE ›
alt_text

Monday, Jul 9 2018

World Hepatitis Day: Hadassah’s Contribution to the Global Battle Against this Disease

“Hadassah Medical Organization's (HMO) greatest contribution to the global battle against Hepatitis are the vaccines that have been developed here,” said Prof. Daniel Shouval, as we mark World Hepatitis Day on July 28.

READ MORE ›
alt_text

Tuesday, Jul 3 2018

Prioritizing Treatment Options in Breast Cancer

When a patient with metastatic breast cancer fails to respond to conventional treatment and gene analysis identifies several targetable molecular mutations, how do you prioritize treatment options?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More